DIRECTOR, USAMRAA, 820 CHANDLER ST, FORT DETRICK MD 21702-5014

A -- PERSIAN GULF WAR ILLNESS RESEARCH SOL 074&&&-9701-0003 POC Contracting Officer Craig D. Lebo (301) 619-2036 (Site Code DAMD17) The U.S. Army Medical Research Acquisition Activity previously announced in the Commerce Business the interest in obtaining proposals for the conduct of research in the area of Persian Gulf War Illness. (see CBD Issue PSA #1738, dated December 10, 196). This previous Department of Defense announcement, which solicited research proposals on Persian Gulf War Illnesses research, is expanded to include two additional topics: (1) causal relationships between illnesses and symptoms among Gulf War veterans ad possible exposures to hazardous material; chemical warfare agents; stress; potentially hazardous combinations of inoculations (ie, anthrax and botulinum toxin) and investigational new drugs (ie, pyridostigmine bromide) during military service in the Southwest Asia theater of operations during the Persian Gulf War, and (2) studies of historical war syndromes, including investigation of factors which create a conflence of cognitive, emotional and physical factors to produce chronic, non-specific symptoms and physiological outcomes (e.g., neurologic, immunologic and endocrine responses). Large scale epidemiological studies must include provisions for scientific and pblic advisory committees as recommended by the Presidential Advisory Committee on Gulf War Veterans' Illnesses and Persian Gulf Veterans Coordinating Board. Approximately $9.5 M in additional funding is available only to principal investigators and institutions independent of the Federal Government in accordance with the provisions of the Byrd Amendment. Proposals should be submitted in accordance with road Agency Announcement 95-1 and received NLT 19 February 1997. (0010)

Loren Data Corp. http://www.ld.com (SYN# 0006 19970114\A-0006.SOL)